- Home
- MGRX vs ADXN Comparison
MGRX vs ADXN Comparison
Compare MGRX & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- ADXN
- Stock Information
- Founded
- MGRX 2021
- ADXN 2002
- Country
- MGRX United States
- ADXN Switzerland
- Employees
- MGRX N/A
- ADXN N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- MGRX Technology
- ADXN Health Care
- Exchange
- MGRX Nasdaq
- ADXN Nasdaq
- Market Cap
- MGRX 8.1M
- ADXN 10.1M
- IPO Year
- MGRX 2023
- ADXN N/A
- Fundamental
- Price
- MGRX $1.50
- ADXN $8.83
- Analyst Decision
- MGRX
- ADXN Strong Buy
- Analyst Count
- MGRX 0
- ADXN 1
- Target Price
- MGRX N/A
- ADXN $30.00
- AVG Volume (30 Days)
- MGRX 156.5K
- ADXN 14.4K
- Earning Date
- MGRX 08-13-2025
- ADXN 08-11-2025
- Dividend Yield
- MGRX N/A
- ADXN N/A
- EPS Growth
- MGRX N/A
- ADXN N/A
- EPS
- MGRX N/A
- ADXN 0.10
- Revenue
- MGRX $511,084.00
- ADXN $278,508.00
- Revenue This Year
- MGRX N/A
- ADXN $86.57
- Revenue Next Year
- MGRX N/A
- ADXN N/A
- P/E Ratio
- MGRX N/A
- ADXN $0.78
- Revenue Growth
- MGRX N/A
- ADXN N/A
- 52 Week Low
- MGRX $1.32
- ADXN $6.51
- 52 Week High
- MGRX $7.66
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- MGRX 45.69
- ADXN 49.41
- Support Level
- MGRX $1.41
- ADXN $8.78
- Resistance Level
- MGRX $2.04
- ADXN $9.89
- Average True Range (ATR)
- MGRX 0.17
- ADXN 0.67
- MACD
- MGRX -0.02
- ADXN -0.03
- Stochastic Oscillator
- MGRX 33.43
- ADXN 43.01
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.